プレスリリース

最新のニュース、発表、パートナーシップをご覧ください。

メディアに関するお問い合わせは、media@inventia.life までご連絡ください。

プレスリリース
Inventia continues global expansion into the Indian market through a distribution agreement for RASTRUM™ with Biotron Healthcare PVT LtdRead More
プレスリリース
Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery
プレスリリース
Inventia enters into a distribution agreement for RASTRUM™ with SCRUM Inc in Japan
プレスリリース
Inventia Life Science secures NSW Government Jobs Plus support to build a brand-new manufacturing and R&D facility in SydneyRead More
プレスリリース
Inventia Life Science cements its US presence by opening its first US office and facility at The Innovation Space™ in Wilmington, DelawareRead More
プレスリリース
Inventia has been named on the 2022 AFR BOSS Most Innovative Companies ListRead More
プレスリリース
Healthcare super fund HESTA directly invests in Inventia Life ScienceRead More
プレスリリース
Clamping down on the causes of pre-eclampsia

A novel 3D placenta bioprinting project could unearth novel biomarkers and treatments for the pregnancy complication pre-eclampsia.

Read More
プレスリリース
Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US MarketRead More
プレスリリース
Australian company accelerating the speed of drug discovery wins prestigious Eureka prizeRead More
プレスリリース
Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discoveryRead More
プレスリリース
Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell modelsRead More
LOAD MORE
Resource Categories
文献 プレスリリースウェビナービデオポスタープロトコールアプリケーションノート